Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern.
Yue LiDonglai ChenYi XuQifeng DingXuejun XuYongzhong LiYedong MiYongbing ChenPublished in: Journal of clinical pathology (2024)
LP+A was a unique histological subtype with a higher EGFR mutation rate, lower tumour mutation burden and immune checkpoint expression levels. Our findings suggested potential benefits from targeted therapy over immunotherapy in LP+A.